These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26866492)

  • 41. Axillary injection of botulinum A toxin in a patient with muscle cramps associated with severe axillary hyperhidrosis.
    Filosto M; Bertolasi L; Fincati E; Priori A; Tomelleri G; Chieregato G; Rizzuto N
    Acta Neurol Belg; 2001 Jun; 101(2):121-3. PubMed ID: 11486559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Botulinum toxin in focal hyperhidrosis. An update].
    Hosp C; Naumann MK; Hamm H
    Hautarzt; 2012 Jun; 63(6):469-76. PubMed ID: 22638981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal.
    Jost WH
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33503872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of objective methods to diagnose palmar hyperhidrosis and monitor effects of botulinum toxin treatment.
    Krogstad AL; Skymne BS; Göran Pegenius BS; Elam M; Wallin BG
    Clin Neurophysiol; 2004 Aug; 115(8):1909-16. PubMed ID: 15261869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Focal hyperhidrosis: diagnosis and management.
    Haider A; Solish N
    CMAJ; 2005 Jan; 172(1):69-75. PubMed ID: 15632408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botulinum toxin for treatment of Harlequin syndrome.
    Manhães RK; Spitz M; Vasconcellos LF
    Parkinsonism Relat Disord; 2016 Feb; 23():112-3. PubMed ID: 26750113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of palmar hyperhidrosis with botulinum toxin.
    Glogau RG
    Semin Cutan Med Surg; 2001 Jun; 20(2):101-8. PubMed ID: 11474742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin for treatment of craniofacial hyperhidrosis.
    Böger A; Herath H; Rompel R; Ferbert A
    J Neurol; 2000 Nov; 247(11):857-61. PubMed ID: 11151418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations.
    Tan EK
    Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis and treatment of primary focal hyperhidrosis in children and adolescents.
    Bellet JS
    Semin Cutan Med Surg; 2010 Jun; 29(2):121-6. PubMed ID: 20579601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of hyperhidrosis with botulinum toxin.
    Doft MA; Hardy KL; Ascherman JA
    Aesthet Surg J; 2012 Feb; 32(2):238-44. PubMed ID: 22328694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin type B: a new therapy for axillary hyperhidrosis.
    Nelson L; Bachoo P; Holmes J
    Br J Plast Surg; 2005 Mar; 58(2):228-32. PubMed ID: 15710119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.
    Chinnapongse R; Gullo K; Nemeth P; Zhang Y; Griggs L
    Mov Disord; 2012 Feb; 27(2):219-26. PubMed ID: 21887710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. OnabotulinumtoxinA therapy for compensatory hyperhidrosis.
    Adefusika JA; Brewer JD
    J Cosmet Dermatol; 2013 Sep; 12(3):232-4. PubMed ID: 23992165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of hyperhidrosis with botulinum toxin.
    Cohen JL; Solish N
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):493-502. PubMed ID: 15062254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperhidrosis in Parkinson's disease.
    Schestatsky P; Valls-Solé J; Ehlers JA; Rieder CR; Gomes I
    Mov Disord; 2006 Oct; 21(10):1744-8. PubMed ID: 16773622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Other indications of botulinum toxin therapy.
    Jost WH
    Eur J Neurol; 2006 Feb; 13 Suppl 1():65-9. PubMed ID: 16417601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences between objective efficacy and perceived efficacy in patients with palmar hyperhidrosis treated with either botulinum toxin or endoscopic thoracic sympathectomy.
    Alvarez MA; Ruano J; Gómez FJ; Casas E; Baamonde C; Salvatierra A; Moreno JC
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e282-8. PubMed ID: 22827710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Botulinum toxin: a novel therapy for clozapine-induced sialorrhoea.
    Verma R; Anand KS
    Psychopharmacology (Berl); 2018 Jan; 235(1):369-371. PubMed ID: 29196826
    [No Abstract]   [Full Text] [Related]  

  • 60. Botulinum neurotoxin serotype A: a clinical update on non-cosmetic uses.
    Charles PD
    Am J Health Syst Pharm; 2004 Nov; 61(22 Suppl 6):S11-23. PubMed ID: 15598005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.